Philips Rolls Out Real-Time, 3D Intracardiac Catheter in Europe

Philips has introduced its VeriSight Pro 3D intracardiac echocardiography (ICE) catheter in Europe. The technology brings real-time 3D imaging inside the heart to help procedures be performed with better clarity, without needing general anesthesia.

VeriSight Pro was designed for procedures like transcatheter valve repair and left atrial appendage closure. It provides high-resolution 2D and 3D visualization inside the heart chambers.

3D ICE imaging offers visualization from within the heart through a catheter introduced via the femoral vein, lowering the need for general anesthesia and recovery time in the Pos-Anesthesia Care Unit (PACU).

VeriSight Pro’s miniaturized ultrasound probe is about three millimeters in diameter, which is embedded at the tip of a thin, steerable catheter. Imaging from inside the heart with control over the scan angle opens new possibilities to guide structural heart interventions, according to Philips.

Clinicians can evaluate anatomy, guide device placement, and confirm procedural results from a single access point without needing more invasive imaging techniques. VeriSight Pro is the first ICE catheter to miniaturize the 3D imaging tech of transesophageal echocardiography (TEE).

The catheter’s unique features—including xPlane and iRotate technologies—allow physicians to visualize two imaging planes simultaneously and digitally adjust views without physically repositioning the catheter tip. These capabilities enable precise assessment and device deployment with fewer imaging steps.

“VeriSight Pro reflects our ongoing commitment to delivering clinically relevant innovations that enhance precision, reduce procedure complexity, and improve the care experience,” said Stacy Beske, Business Leader of Image-Guided Therapy Devices at Philips. “Its availability in Europe is an important milestone in helping more patients benefit from image-guided, minimally invasive heart procedures, while supporting care teams with integrated solutions that adapt to the way they work.”

VeriSight Pro is part of Philips’ structural heart disease ecosystem, seamlessly integrating with Philips’ Epiq ultrasound systems, which in turn integrate with the Azurion image-guided therapy platform. Combined with tools such as EchoNavigator, the company offers an end-to-end solution for clinicians performing procedures such as tricuspid and mitral valve repair and replacement, atrial septal defect closure, and left atrial appendage occlusion.